NASDAQ:ZFGN Zafgen (ZFGN) Stock Price, News & Analysis → $16T Crypto Plot From Elon Musk (From Crypto 101 Media) (Ad) Free ZFGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$7.92▼$9.4650-Day Range$0.99▼$25.0652-Week Range$0.62▼$2.76Volume579,140 shsAverage Volume360,199 shsMarket Capitalization$299.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsTrendsStock AnalysisCompetitorsTrends Get Zafgen alerts: Email Address Ad Oasis GoldThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with their own controllable, traceable, programmable digital currency.Act now and claim your free information kit before it's too late! About Zafgen Stock (NASDAQ:ZFGN)Zafgen, Inc., a clinical-stage biopharmaceutical company, develops therapies for patients suffering from metabolic diseases comprising type 2 diabetes, Prader-Willi syndrome (PWS), and other metabolically related disorders. The company's lead product candidate is ZGN-1061, a fumagillin-class methionine aminopeptidase 2 (MetAP2) inhibitor administered by subcutaneous injection, which is in Phase 2 clinical trial and profiled for its utility in the treatment of type 2 diabetes and other related metabolic disorders. It also develops ZGN-1258, a MetAP2 inhibitor for treatment of PWS. Zafgen, Inc. was founded in 2005 and is headquartered in Boston, Massachusetts.Read More Ad Oasis GoldThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with their own controllable, traceable, programmable digital currency.Act now and claim your free information kit before it's too late! ZFGN Stock News HeadlinesMay 16, 2024 | morningstar.comTokyo Steel Manufacturing Co Ltd 5423April 9, 2023 | marketwatch.comGlobal Weight Loss Therapeutics Professional Market 2023 (Exclusive Report) | Future Work Trend by 2030June 18, 2024 | DTI (Ad)Do NOT Buy the Fidelity and Blackrock Bitcoin ETFs - Here’s whyBefore you buy the newly approved Bitcoin ETFs… Take a look at this “Better than Bitcoin ticker” you can buy in any regular brokerage account. Why? Because it’s been shown to outperform Bitcoin by 10X or more during the past four bull runs… For example, while Bitcoin surged 985% during the last bull run in 2021… February 26, 2023 | thestreet.comZafgen (ZFGN) Stock Skyrockets on Positive Obesity Drug ResultsJanuary 13, 2023 | thestreet.comZafgen (ZFGN) Stock Surges on Positive Obesity Drug TrialNovember 8, 2022 | bbc.co.ukFood and drink in a castleSeptember 30, 2022 | seekingalpha.comLRMR Larimar Therapeutics, Inc.September 14, 2022 | streetinsider.comForm 424B5 Larimar Therapeutics, - StreetInsider.comJune 18, 2024 | DTI (Ad)Do NOT Buy the Fidelity and Blackrock Bitcoin ETFs - Here’s whyBefore you buy the newly approved Bitcoin ETFs… Take a look at this “Better than Bitcoin ticker” you can buy in any regular brokerage account. Why? Because it’s been shown to outperform Bitcoin by 10X or more during the past four bull runs… For example, while Bitcoin surged 985% during the last bull run in 2021… April 12, 2022 | streetinsider.comForm DEF 14A Larimar Therapeutics, For: May 10 - StreetInsider.comMarch 25, 2022 | marketscreener.comLARIMAR THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.comNovember 12, 2021 | marketscreener.comLARIMAR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.comNovember 12, 2021 | streetinsider.comLarimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results - StreetInsider.comNovember 12, 2021 | globenewswire.comLarimar Therapeutics Reports Third Quarter 2021 Operating - GlobeNewswireOctober 22, 2021 | finance.yahoo.comAnti-Obesity Therapeutics Market Research Report by Mechanism of Action, by Drug Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo FinanceOctober 20, 2021 | benzinga.comAnti-Obesity Therapeutics Market Research Report by Mechanism of Action, by Drug Type, by Region - Global - BenzingaSeptember 21, 2021 | streetinsider.comFauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery - StreetInsider.comSeptember 21, 2021 | prnewswire.comFauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery - PRNewswireAugust 2, 2021 | seekingalpha.comVividion Therapeutics Begins U.S. IPO Effort - Seeking AlphaSee More Headlines Receive ZFGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zafgen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2020Today6/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ZFGN CUSIPN/A CIK1374690 Webwww.zafgen.com Phone617-622-4003FaxN/AEmployees38Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,410,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-51.34% Return on Assets-34.55% Debt Debt-to-Equity Ratio0.26 Current Ratio6.56 Quick Ratio6.56 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.35 per share Price / Book5.92Miscellaneous Outstanding Shares37,470,000Free FloatN/AMarket Cap$299.39 million OptionableNot Optionable Beta0.27 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Jeffrey S. Hatfield (Age 61)CEO & Director Ms. Patricia L. Allen (Age 57)Chief Financial Officer Dr. Dennis D. Kim M.D. (Age 49)MBA, Chief Medical Officer Dr. James E. Vath (Age 58)Head of Discovery & Devel. Mr. Brian P. McVeigh (Age 46)Chief Bus. Officer Key CompetitorsANI PharmaceuticalsNASDAQ:ANIPXencorNASDAQ:XNCRPacira BioSciencesNASDAQ:PCRXKiniksa PharmaceuticalsNASDAQ:KNSAMannKindNASDAQ:MNKDView All Competitors ZFGN Stock Analysis - Frequently Asked Questions How were Zafgen's earnings last quarter? Zafgen Inc (NASDAQ:ZFGN) released its earnings results on Thursday, March, 5th. The biopharmaceutical company reported ($0.19) earnings per share for the quarter, meeting the consensus estimate of ($0.19). What other stocks do shareholders of Zafgen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Zafgen investors own include SCYNEXIS (SCYX), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), Energy Transfer (ET), TG Therapeutics (TGTX), BlackRock (BLK), Fate Therapeutics (FATE), Pfizer (PFE), Spectrum Pharmaceuticals (SPPI) and Esperion Therapeutics (ESPR). This page (NASDAQ:ZFGN) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zafgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
